{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:22:03Z","timestamp":1791976923580,"version":"4.4.0"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:00:00Z","timestamp":1604793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the prevalence and risk factors of drug\u2010resistant tuberculosis (TB), the fifth national anti\u2010TB drug resistance survey was conducted in Thailand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross\u2010sectional study was conducted by stratified cluster sampling with probability proportional to size of TB cases from public health facilities in 100 clusters throughout Thailand from August 2017 to August 2018. Susceptibility testing of TB isolates to first\u2010 and second\u2010line anti\u2010TB drugs was performed on L\u00f6wenstein\u2013Jensen medium using the indirect proportion method. Multiple imputation was done for handling missing data using Stata 16. The proportion of TB cases with drug resistance was determined. The odds ratio was used to evaluate risk factors associated with drug\u2010resistant TB.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 1501 new TB and 69 previously treated TB cases, 14.0% [95% confidence interval (CI): 12.1\u201316.1] and 33.4% (95% CI: 23.6\u201344.8), respectively, had resistance to any anti\u2010TB drug. Multidrug\u2010resistant TB accounted for 0.8% (95% CI: 0.5\u20131.4) of new TB cases and 13.0% (95% CI: 6.5\u201324.4) of previously treated TB cases. Drug\u2010resistant TB was associated with prior TB treatment [odds ratio (OR), 2.9; 95% CI: 1.6\u20135.0], age at 45\u201354\u00a0years (OR, 1.6; 95% CI: 1.0\u20132.4), male (OR, 1.5; 95% CI: 1.0\u20132.1) and human immunodeficiency virus (HIV) infection (OR, 1.6; 95% CI: 1.0\u20132.4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The burden of drug\u2010resistant TB remains high in Thailand. Intensified prevention and control measures should be implemented to reduce the risks of drug\u2010resistant TB in high\u2010risk groups previously treated, especially individuals of late middle age, males and those with coinfection of TB and HIV.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tmi.13502","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T19:47:56Z","timestamp":1601495276000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence and associated risk factors of drug\u2010resistant tuberculosis in Thailand: results from the fifth national anti\u2010tuberculosis drug resistance survey"],"prefix":"10.1111","volume":"26","author":[{"given":"P.","family":"Kamolwat","sequence":"first","affiliation":[{"name":"Division of Tuberculosis Department of Disease Control Ministry of Public Health  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nateniyom","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Department of Disease Control Ministry of Public Health  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chaiprasert","sequence":"additional","affiliation":[{"name":"Office of Research and Development Faculty of Medicine Siriraj Hospital Mahidol University  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Disratthakit","sequence":"additional","affiliation":[{"name":"Division of Genomic Medicine and Innovation Support Department of Medical Sciences Ministry of Public Health  Nonthaburi Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mahasirimongkol","sequence":"additional","affiliation":[{"name":"Division of Genomic Medicine and Innovation Support Department of Medical Sciences Ministry of Public Health  Nonthaburi Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yamada","sequence":"additional","affiliation":[{"name":"Centre for International Cooperation and Global TB information The Research Institute of Tuberculosis Japan Anti\u2010Tuberculosis Association  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Smithtikarn","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Department of Disease Control Ministry of Public Health  Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,8]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"Guidelines for Surveillance of Drug Resistance in Tuberculosis","author":"World Health Organization","year":"2015"},{"key":"e_1_2_6_3_1","volume-title":"Tuberculosis Drug Resistance in the World","author":"World Health Organization","year":"1997"},{"key":"e_1_2_6_4_1","volume-title":"Anti\u2010Tuberculosis Drug Resistance in the World: Third Global Report","author":"World Health Organization","year":"2004"},{"key":"e_1_2_6_5_1","volume-title":"Anti\u2010Tuberculosis Drug Resistance in the World: Report No. 4","author":"World Health Organization","year":"2008"},{"key":"e_1_2_6_6_1","volume-title":"Standards and Benchmarks for Tuberculosis Surveillance and Vital Registration: Checklist and User Guide","author":"World Health Organization","year":"2014"},{"key":"e_1_2_6_7_1","volume-title":"Tuberculosis Prevalence Surveys: A Handbook","author":"World Health Organization","year":"2011"},{"key":"e_1_2_6_8_1","first-page":"61","volume-title":"Chapter 5 \u2010 Biochemical Tests and Staining Techniques for Microbial Identification","author":"Wanger A","year":"2017"},{"key":"e_1_2_6_9_1","unstructured":"Global Laboratory Initiative a Working Group of the Stop TB Partnership. Global laboratory initiative advancing TB diagnosis Mycobacteriology Laboratory Manual. GLI;2014."},{"key":"e_1_2_6_10_1","volume-title":"Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis","author":"World Health Organization","year":"2018"},{"key":"e_1_2_6_11_1","first-page":"565","article-title":"Micrcobacteria: Laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti G","year":"1961","journal-title":"Bull World Health Organ"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01463-09"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"e_1_2_6_14_1","volume-title":"Stata Statistical Software: Release 16","author":"StataCorp","year":"2019"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i01"},{"key":"e_1_2_6_16_1","volume-title":"Global Tuberculosis Report 2018 [Internet]","author":"World Health Organization","year":"2018"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.11.008"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071212"},{"key":"e_1_2_6_19_1","first-page":"281","article-title":"Early and late tuberculosis risks among close contacts in Hong Kong","volume":"12","author":"Lee MSN","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0030"},{"key":"e_1_2_6_21_1","volume-title":"Adherence to Long\u2010Term Therapies: Evidence for Action","author":"World Health Organization","year":"2003"},{"key":"e_1_2_6_22_1","first-page":"1","article-title":"Predictors of noncompliance to pulmonary tuberculosis treatment: an insight from South America","volume":"13","author":"Oliveira SM","year":"2018","journal-title":"PLoS One"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2458-10-381","article-title":"Gender\u2010related factors influencing tuberculosis control in shantytowns: a qualitative study","volume":"10","author":"Onifade DA","year":"2010","journal-title":"BMC Public Health"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2018.0126"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.93376"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"ofw248","DOI":"10.1093\/ofid\/ofw248","article-title":"Improving TB and HIV treatment monitoring in South Africa: evaluation of an advanced TB\/HIV course for health care workers","volume":"4","author":"Galagan S","year":"2016","journal-title":"Open Forum Infect Dis"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.13502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tmi.13502","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.13502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T17:06:19Z","timestamp":1693760779000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tmi.13502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,8]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1111\/tmi.13502"],"URL":"https:\/\/doi.org\/10.1111\/tmi.13502","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,8]]},"assertion":[{"value":"2020-11-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}